Intrinsic cellular heterogeneity directs divergent epithelial‐to‐mesenchymal transition outcomes
The FEBS Journal · 2026
DOI: 10.1111/febs.70458 ↗At a glance
Journal article in The FEBS Journal, 2026. Written by Esin Ozkuru Sekeroglu and 9 co-authors. Institution: Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Turkey. Major MEDLINE topics: Epithelial-Mesenchymal Transition, Cadherins. 54 references. The full text is freely available in PubMed Central. Funded by: Dokuz Eylül University, Araştırma Üniversiteleri Destek Programı (ADEP), Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (original language)
Epithelial‐to‐mesenchymal transition (EMT) is a fundamental process in development and disease; however, its study is often complicated by the intrinsic heterogeneity of commonly used epithelial cell models. Here, we show that pre‐existing heterogeneity contributes to divergent outcomes following transforming growth factor‐beta 3 (TGFβ3) treatment. Flow cytometry, gene expression profiling and imaging revealed persistent variability in E‐cadherin (E‐cad) and epithelial cell adhesion molecule (EpCAM) expression, with differentially sorted subpopulations displaying distinct transcriptional responses. Remarkably, some single‐cell‐derived clones exhibited paradoxical CDH1 upregulation during EMT, coinciding with GRHL3 induction and reflecting context‐specific regulatory plasticity. Additionally, forskolin‐mediated cyclic adenosine monophosphate (cAMP) activation enhanced epithelial stability and modulated EMT dynamics by preserving membrane‐localised E‐cadherin without preventing transcriptional repression of CDH1 . Comparison with an epithelial subclone model further demonstrated how baseline identity shapes EMT trajectories. Moreover, in vivo analysis using zebrafish xenografts revealed that intrinsic epithelial features were associated with differential dissemination potential, reinforcing the connection between cellular identity and metastatic behaviour. These findings underline the importance of accounting for inherent heterogeneity in EMT models and demonstrate how intrinsic regulatory states and extrinsic signals intersect to shape epithelial plasticity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Turkey.
- İzmir Biomedicine and Genome Center, Turkey.
ORCID profiles: Esin Ozkuru Sekeroglu, Şeyma N Yıldız, Seray Yetkin, Esra Ersöz Gülseven, Gulcin Cakan-Akdogan, Tugce Batur, Hani Alotaibi
Funding
- Dokuz Eylül University, Araştırma Üniversiteleri Destek Programı (ADEP)
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Cite
APA
Ozkuru Sekeroglu, E., Yıldız, Ş. N., Yetkin, S., Kafaz, G. I., Sengez, B., Erez, O., Ersöz Gülseven, E., Cakan-Akdogan, G., Batur, T., & Alotaibi, H. (2026). Intrinsic cellular heterogeneity directs divergent epithelial‐to‐mesenchymal transition outcomes. The FEBS Journal. https://doi.org/10.1111/febs.70458
Vancouver
Ozkuru Sekeroglu E, Yıldız ŞN, Yetkin S, Kafaz GI, Sengez B, Erez O, et al. Intrinsic cellular heterogeneity directs divergent epithelial‐to‐mesenchymal transition outcomes. The FEBS Journal. 2026. doi:10.1111/febs.70458
BibTeX
@article{OzkuruSekeroglu2026,
author = {Ozkuru Sekeroglu, Esin and Yıldız, Şeyma N and Yetkin, Seray and Kafaz, Gkamze Impraimoglou and Sengez, Burcu and Erez, Ozlem and Ersöz Gülseven, Esra and Cakan-Akdogan, Gulcin and Batur, Tugce and Alotaibi, Hani},
title = {Intrinsic cellular heterogeneity directs divergent epithelial‐to‐mesenchymal transition outcomes},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70458}
}
EUVIMED